P212. Sarcopenia is Associated with Distal Junctional Failure Following Posterior Cervical Fusion Surgery
Muhammad Zulfiqar,Hanzhi Yang,Jialun Chi,Jesse Wang,Lawal Labaran,Yi Zhang,Stephen Daniel Lockey,Xudong Joshua Li
DOI: https://doi.org/10.1016/j.spinee.2024.06.335
IF: 4.297
2024-01-01
The Spine Journal
Abstract:BACKGROUND CONTEXT Sarcopenia, a progressive condition marked by the decline in muscle mass and function, is increasingly recognized as a significant factor influencing outcomes in spinal surgery. Despite the growing body of research linking sarcopenia to adverse outcomes in various surgical fields, the specific implications of sarcopenia in cervical deformity surgery—a domain with a wide range of procedural complexities—remains underexplored. PURPOSE The purpose of this investigation was to compare surgical outcomes and complications in patients undergoing posterior cervical fusion for deformity with and without a diagnosis of sarcopenia. STUDY DESIGN/SETTING Retrospective, observational. PATIENT SAMPLE The study population included adult patients who underwent posterior cervical fusion for cervical deformity from 2015 to 2020. Surgical intervention involving C1/C2 level were excluded. Patients with active or recent history of trauma, infection, or malignancy of the cervical spine were excluded from the population. Patients were then separated into two groups based on the presence of sarcopenia. Surgical parameters were matched and included number of posterior instrumentation level, osteotomy type, and previous cervical spine surgery. All patients were followed-up for two years from the index procedure. OUTCOME MEASURES Patients in both groups were evaluated for medical complications including cardiopulmonary, central nervous system, gastrointestinal, renal, and infectious conditions. Surgical complications included operative, neurological, wound/surgical site infections (SSIs), mechanical/structural including distal junctional failure and reoperation at two years. In addition, the incidence of 90-day emergency department visits, hospital readmission, and two-year mortality were documented. METHODS Pearson χ2 test was used to assess for differences in demographics, preexisting comorbidities, and surgical parameters. Multivariable logistic regression was used to determine the effects of sarcopenia on the postoperative outcomes after adjusting for demographics and comorbidities. All statistical analyses were conducted using the research query interface provided by PearlDiver Bellwether. The common statistical metrics, including frequencies, mean values, and odds ratios (ORs), were collected by the Bellwether system using the R statistical package. Statistical significance was set at p < 0.05. RESULTS The study included 1,870 patients, with 312 sarcopenic patients and 1,558 controls, with matched demographics to ensure comparability. The frail group exhibited more comorbidities like diabetes, chronic kidney disease, and depression (p<0.05). Surgical parameters were evenly distributed between the two groups.The analysis of medical complications revealed a significantly higher risk among sarcopenic patients for cardiopulmonary events including arrhythmias, myocardial infarction, atelectasis, respiratory failure, and pleural effusion. Frail patients also had higher rates of cerebrovascular accident and renal complications such as electrolyte imbalance, renal failure, and urinary retention. Additionally, frail patients experienced higher rates of infectious complications such as pneumonia, sepsis, and urinary tract infections (p<0.05). Surgical complications were notably more frequent in the sarcopenia group, particularly for transfusion requirement after surgery. The study also observed significant differences in wound-related complications including wound dehiscence and hematoma. Rates of distal junctional failure was elevated in sarcopenic individuals as well (p<0.05). Interestingly, the reoperation rate at postoperative year two was not significantly different. CONCLUSIONS The presence of sarcopenia in patients undergoing posterior cervical fusion for cervical deformity significantly increases the risk of adverse postoperative events, namely wound complications and distal junctional failure. Incorporating an assessment for sarcopenia during the preoperative evaluation may better inform surgical decision-making and postoperative care. FDA Device/Drug Status This abstract does not discuss or include any applicable devices or drugs.